Clinical and mycological efficacy of single-day oral treatment with itraconazole (400 mg) in acute vulvovaginal candidosis

Mycoses

Volumn 47, Issue 9-10, 2004, Pages 422-427

  Urünsak, Macit ^a   Ilkit, M ^a   Evruke C ^a   Urunsak I ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Antimycotic chemotherapy; Candida; Candidosis; Itraconazole; Vulvovaginitis

Indexed keywords

CLOTRIMAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ABDOMINAL PAIN; ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KEFYR; CANDIDA KRUSEI; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNGUS CULTURE; FUNGUS HYPHAE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MICROSCOPY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; VAGINA CANDIDIASIS; VAGINA DISCHARGE; YEAST CELL;

ADMINISTRATION, ORAL; ADULT; ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; ITRACONAZOLE; MIDDLE AGED; TREATMENT OUTCOME;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; FUNGI; ISSATCHENKIA ORIENTALIS; KLUYVEROMYCES MARXIANUS;

EID: 7944238320     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2004.01023.x     Document Type: Article

References (25)

1. Weinstein L. Gynecologic infections. In: Sciarria JJ (ed.), Gynecology and Obstetrics. Vol. 1. Lippincott: Williams & Wilkins, CD-ROM, 1999.
2. Tümbay E, Metin DY. Üro-genital kandidozlar. In: Kiraz N, Kiremitçi A & Akgün Y (eds), Candida Mikrobiyolojisi ve Infeksiyonlari Simpozyumu (21-22 Haziran 2002. Eskişehir)-Tutanaklar. Türk Mikrobiyoloji Cemiyeti Yayin: No: 43, Eskişehir: OGÜ Basimevi, 2002: 101-9.
3. Sobel JD. Genital candidiasis. In: Bodey GP (ed.). Candidiasis: Pathogenesis, Diagnosis and Treatment. 2nd edn. New York: Raven Press, 1993: 225-47.
4. Richardson MD, Warnock DW. Fungal Infection - Diagnosis and Management. 2nd edn. Oxford: Blackwell Science, 1997: 78-93, 131-48.
5. Hurley R, De Louvois J. Candida vaginitis. Postgrad Med J 1979; 55: 645-7.
6. Baron EI, Cassell GH, Duffy LB et al. Laboratory diagnosis of female genital tract infections. In: Baron EI (ed.), Cumulative Techniques and Procedures in Clinical Microbiology (Cumitech) 17A. Washington DC: ASM Press, 1993: 1-28.
7. Sobel JD, Faro S, Force RW et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998; 178: 203-11.
8. Sobel JD. Mucocutaneous candidiasis. In: Mandell GL & Diamond RD (eds). Atlas of Infectious Diseases. Philadelphia: Current Medicine, 2000: 117-33.
9. İnci R. Antifungal ilaçlar. In: Topçu Willke A, Söyletir G & Doǧanay M (eds). İnfeksiyon Hastaliklari ve Mikrobiyolojisi. 2. Baski: İstanbul: Nobel Tip Kitabevleri. 2002: 296-308.
10. Woolley PD, Higgins SP. Comparison of clotrimazole, fluconazole and itraconazole in vaginal candidiasis. Br J Clin Pract 1995; 49: 65-6.
11. Buckley HR. Identification of yeasts. In: Evans EGV & Richardson MD (eds), Medical Mycology: A Practical Approach. Oxford: IRL Press. 1989: 97-109.
12. İnci R. Vulvo-vaginal kandidoz tedavisi. In: Aǧaçfidan A & Ang Ö (eds). Cinsel Temasla Bulaşan Hastaliklar (CTBH). Türk Mikrobiyoloji Cemiyeti Yayini No: 35. İstanbul: Faik Yolaç Ofset Basim. 1999: 383-5.
13. Tanaka D. Management of vaginal candidiasis: a review. Rev Pediatr Infect Dis 1998; 17: 746-7.
14. Arikan S. Candida infeksiyonlarinin tedavisinde duyarlilik testlerinin önemi. In: Kiraz N, Kiremitçi A & Akgün Y (eds). Candida Mikrobiyolojisi ve i̇nfeksiyonlari Simpozyumu (21-22 Haziran 2002, Eskişehir)-Tutanaklar. Türk Mikrobiyoloji Cemiyeti Yayini No: 43. Eskişehir: OGÜ Basimevi, 2002: 161-7.
15. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard NCCLS Document M27-A. Wayne, PA: National Committee for Laboratory Standards, 1997.
16. Cauwenbergh G. Itracanozole: the first orally active antifungal for single-day treatment of vaginal candidosis. Curr Ther Res Opin 1987; 41: 210-4.
17. Heykants J, Van Peer A, Lavrijsen K, Meuldermans W, Woestenborghs R, Cauwenbergh G. Pharmacokinetics of oral antifungals and their implications. Br J Clin Pract 1990; 44: 50-6.
18. Jansen TM, Van de Ven AA-M, Borgers MJ, Odds FC, Van Cutsem JMP. Fungal morphology after treatment with itraconazole as a single oral dose in experimental vaginal candidosis in rats. Am J Obstet Gynecol 1991; 165: 1552-7.
19. Johnson EM, Warnock DW, Lucker J, Porter SR, Scully C. Emergence of azole drug resistance in Candida from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother 1995; 35: 103-14.
20. Wingard JR. Infections due to resistant Candida species patients with cancer who are receiving chemotherapy. Clin Infect Dis 1994; 9: 49-53.
21. White DJ, Johnson EM, Warnock DW. Management of persistent vulvo vaginal candidiosis due to azole-resistant Candida glabrata. Genitourin Med 1993; 69: 112-4.
22. Candido RC, Toloi MRT, Franceschini SA, Garcia FR, Minto ECM. In vitro activity of antimycotic agents determined by E-test method against vaginal Candida species. Mycopathologia 1999; 144: 15-20.
23. Roongpisuthipong A, Sentrakul P, Bhiraleus P, Dusitsin N, Sukroongreung S, Pupaibul K. Itraconazole in the treatment of acute vaginal candidosis. J Med Assoc Thai 1992; 75: 30-4.
24. Stein GE, Mummaw N. Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiosis. Antimicrob Agents Chemother 1993; 37: 89-92.
25. Beyer GPJ, Voorhoove-den Hartog HJ. Day-to-day follow-up after a short oral treatment of acute vaginal candidiosis with itraconazole. Mycoses 1992; 35: 99-101.